Jeil Pharma Holdings Inc 002620.KS Stock
Jeil Pharma Holdings Inc Price Chart
Jeil Pharma Holdings Inc 002620.KS Financial and Trading Overview
| Jeil Pharma Holdings Inc stock price | 10400 KRW |
| Previous Close | 11170 KRW |
| Open | 11280 KRW |
| Bid | 11150 KRW x 0 |
| Ask | 11160 KRW x 0 |
| Day's Range | 11110 - 11400 KRW |
| 52 Week Range | 9100 - 18650 KRW |
| Volume | 4.13K KRW |
| Avg. Volume | 24.28K KRW |
| Market Cap | 172.54B KRW |
| Beta (5Y Monthly) | 1.465132 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | 50 (0.44%) |
| Ex-Dividend Date | December 28, 2022 |
| 1y Target Est | N/A |
002620.KS Valuation Measures
| Enterprise Value | 366.04B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.21812713 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.463 |
| Enterprise Value/EBITDA | 13.553 |
Trading Information
Jeil Pharma Holdings Inc Stock Price History
| Beta (5Y Monthly) | 1.465132 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 18650 KRW |
| 52 Week Low | 9100 KRW |
| 50-Day Moving Average | 12097 KRW |
| 200-Day Moving Average | 12279.8 KRW |
002620.KS Share Statistics
| Avg. Volume (3 month) | 24.28K KRW |
| Avg. Daily Volume (10-Days) | 11.96K KRW |
| Shares Outstanding | 15.35M |
| Float | 2.17M |
| Short Ratio | N/A |
| % Held by Insiders | 82.53% |
| % Held by Institutions | 0.051% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | 40.00% |
| Payout Ratio | N/A |
| Last Split Factor | 0:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -7.82% |
| Operating Margin (ttm) | 1.92% |
| Gross Margin | 25.20% |
| EBITDA Margin | 3.41% |
Management Effectiveness
| Return on Assets (ttm) | 1.05% |
| Return on Equity (ttm) | -12.56% |
Income Statement
| Revenue (ttm) | 791.03B KRW |
| Revenue Per Share (ttm) | 51525.16 KRW |
| Quarterly Revenue Growth (yoy) | -6.60% |
| Gross Profit (ttm) | N/A |
| EBITDA | 27.01B KRW |
| Net Income Avi to Common (ttm) | -61889892352 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | 102.00% |
Balance Sheet
| Total Cash (mrq) | 68.87B KRW |
| Total Cash Per Share (mrq) | 4488.02 KRW |
| Total Debt (mrq) | 161.54B KRW |
| Total Debt/Equity (mrq) | 35.92 KRW |
| Current Ratio (mrq) | 0.986 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13891387392 KRW |
| Levered Free Cash Flow (ttm) | -4208116224 KRW |
Profile of Jeil Pharma Holdings Inc
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | 343, Sapyeong-daero |
| ZIP | 06543 |
| Phone | 82 2 549 7451 |
| Website | https://www.jeilpharm.co.kr |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.
Q&A For Jeil Pharma Holdings Inc Stock
What is a current 002620.KS stock price?
Jeil Pharma Holdings Inc 002620.KS stock price today per share is 10400 KRW.
How to purchase Jeil Pharma Holdings Inc stock?
You can buy 002620.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jeil Pharma Holdings Inc?
The stock symbol or ticker of Jeil Pharma Holdings Inc is 002620.KS.
Which industry does the Jeil Pharma Holdings Inc company belong to?
The Jeil Pharma Holdings Inc industry is Drug Manufacturers-Specialty & Generic.
How many shares does Jeil Pharma Holdings Inc have in circulation?
The max supply of Jeil Pharma Holdings Inc shares is 15.35M.
What is Jeil Pharma Holdings Inc Price to Earnings Ratio (PE Ratio)?
Jeil Pharma Holdings Inc PE Ratio is now.
What was Jeil Pharma Holdings Inc earnings per share over the trailing 12 months (TTM)?
Jeil Pharma Holdings Inc EPS is 0 KRW over the trailing 12 months.
Which sector does the Jeil Pharma Holdings Inc company belong to?
The Jeil Pharma Holdings Inc sector is Healthcare.